GORE VIATORR? TIPS ENDOPROSTHESIS

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,litera report with the FDA on 2017-04-20 for GORE VIATORR? TIPS ENDOPROSTHESIS manufactured by W.l. Gore & Associates.

Event Text Entries

[73328890] A device lot number was not provided; therefore, an investigation was unable to be performed and a cause of the reported event was unable to be determined. Zhang, michael, valentino, michael a.. Bilhemia: a rare complication of transjugular intraheptic portosytemic shunt. Acg case reports journal. 2015; 3(1):60-62
Patient Sequence No: 1, Text Type: N, H10


[73328891] This information was received through case report? Bilhemia: a rare complication of transjugular intraheptic portosytemic shunt? Published in acg case reports journal, october 2015. The abstract reports a (b)(6) woman with cirrhosis due to (b)(6) underwent esophagogastroduodenoscopy for evaluation and banding of esophageal varices. During the procedure, a large varix ruptured, requiring an emergent tips procedure to control the hemorrhage using a 10 x 10 mm gore? Viatorr? Covered stent. Following tips, the patient experienced a rapid rise in serum bilirubin with no evidence of biliary obstruction or hepatic injury. She was determined to have bilhemia, a rare but serious complication of tips. Fifteen days after the tips procedure, an endoscopic retrograde cholangiopancreatography was performed to evaluate for evidence of a biliary-venous fistula. No evidence of a fistula or bile duct dilatation was found. A common bile duct stent was placed and sphincterotomy was performed in an attempt to lower the biliary pressure in order to reduce the flow of bile through a potentially unseen fistula. Despite this procedure, the patient? S bilirubin continued to rise, and a venogram to visualize and occlude the biliary-venous fistula was unremarkable. It was determined that the only viable way to reverse the bilhemia was through liver transplantation. During her hospital course, the patient developed a resistant klebsiella bacteremia. Even with appropriate treatment, she remained persistently bacteremic, possibly due to seeding of her tips. She developed sepsis complicated by renal failure and was transferred back to the intensive care unit. Unfortunately, the patient? S infection precluded her from undergoing liver transplantation and, after multiple discussions with the patient and her family, she was ultimately discharged home with hospice care.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007284313-2017-00100
MDR Report Key6508239
Report SourceCOMPANY REPRESENTATIVE,LITERA
Date Received2017-04-20
Date of Report2017-03-24
Date of Event2015-10-09
Date Added to Maude2017-04-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMARCI STEWART
Manufacturer Street1500 N. 4TH STREET
Manufacturer CityFLAGSTAFF AZ
Manufacturer Phone9285263030
Manufacturer G1MEDICAL PHOENIX 1 B/P
Manufacturer Street32360 N. NORTH VALLEY PARKWAY
Manufacturer CityPHOENIX AZ 85085
Manufacturer CountryUS
Manufacturer Postal Code85085
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameGORE VIATORR? TIPS ENDOPROSTHESIS
Generic NameSHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS
Product CodeMIR
Date Received2017-04-20
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerW.L. GORE & ASSOCIATES
Manufacturer AddressFLAGSTAFF AZ


Patients

Patient NumberTreatmentOutcomeDate
101. Life Threatening; 2. Other 2017-04-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.